Johan Skog, CSO at Exosomes Diagnostics to Present at 2nd Cancer Markers & Liquid Biopsies
Boston, MA, May 07, 2016 --(PR.com)-- Johan Skog, CSO at Exosomes Diagnostics, will give a presentation on the current progress in exosome applications at GTCbio’s 2nd Cancer Markers & Liquid Biopsies Conference to be held on July 6-7, 2016 in Boston, MA.
Dr. Skog is the Chief Scientific Officer and founding scientist of Exosome Diagnostics. Dr. Skog is a well-published thought leader in the field of exosome science having pioneered breakthrough discoveries about exosomes and other microvesicles and their vital role as cell messengers and disease proliferators. While at Massachusetts General Hospital/Harvard Medical School, Dr. Skog was the first to show that tumor-derived mutations can be detected in exosome RNA from serum and other biofluids, findings which were published in Nature Cell Biology in 2008. Additionally, he demonstrated that exosomes serve to deliver messages to other cells, inducing changes favorable to the proliferation of cancer. At Exosome Diagnostics, Dr. Skog continues to make critical advancements in diagnostics and expand the field of exosome biology. Dr. Skog’s research background includes virology, gene therapy, brain tumors, RNA and biomarker discovery.
Dr. Skog and other leaders in industry and academia will discuss platforms for isolating and studying CTCs. Technologies such as next generation sequencing and digital PCR are gaining momentum in these research areas. Biomarker sensitivity, stability, validation, and how we can use markers to follow up with patients and improve the quality of life, will also be discussed.
Session Topics:
I. Isolation, Characterization & Diagnostic Applications of CTCs
II. Advances in the Clinical Application of Circulating Nucleic Acids
III. Validation & Application of Cancer Specific Markers
IV. Current Progress in Exosome Application
V. Clinical & Biological Challenges in Liquid Biopsy
This conference is also part of our larger Molecular Diagnostics Summit, which includes two additional conferences:
2nd Cancer Markers & Liquid Biopsies
Precision Medicine
Digital PCR & qPCR
For more information, please visit website: www.gtcbio.com/conferences/cancer-markers-liquid-biopsies-overview
GTCbio
635 W. Foothill Blvd
Monrovia, CA 91016
www.gtcbio.com/
Email: infogtcbio@gtcbio.com
Phone: (626) 256-6405
Fax: (626) 466-4433
Dr. Skog is the Chief Scientific Officer and founding scientist of Exosome Diagnostics. Dr. Skog is a well-published thought leader in the field of exosome science having pioneered breakthrough discoveries about exosomes and other microvesicles and their vital role as cell messengers and disease proliferators. While at Massachusetts General Hospital/Harvard Medical School, Dr. Skog was the first to show that tumor-derived mutations can be detected in exosome RNA from serum and other biofluids, findings which were published in Nature Cell Biology in 2008. Additionally, he demonstrated that exosomes serve to deliver messages to other cells, inducing changes favorable to the proliferation of cancer. At Exosome Diagnostics, Dr. Skog continues to make critical advancements in diagnostics and expand the field of exosome biology. Dr. Skog’s research background includes virology, gene therapy, brain tumors, RNA and biomarker discovery.
Dr. Skog and other leaders in industry and academia will discuss platforms for isolating and studying CTCs. Technologies such as next generation sequencing and digital PCR are gaining momentum in these research areas. Biomarker sensitivity, stability, validation, and how we can use markers to follow up with patients and improve the quality of life, will also be discussed.
Session Topics:
I. Isolation, Characterization & Diagnostic Applications of CTCs
II. Advances in the Clinical Application of Circulating Nucleic Acids
III. Validation & Application of Cancer Specific Markers
IV. Current Progress in Exosome Application
V. Clinical & Biological Challenges in Liquid Biopsy
This conference is also part of our larger Molecular Diagnostics Summit, which includes two additional conferences:
2nd Cancer Markers & Liquid Biopsies
Precision Medicine
Digital PCR & qPCR
For more information, please visit website: www.gtcbio.com/conferences/cancer-markers-liquid-biopsies-overview
GTCbio
635 W. Foothill Blvd
Monrovia, CA 91016
www.gtcbio.com/
Email: infogtcbio@gtcbio.com
Phone: (626) 256-6405
Fax: (626) 466-4433
Contact
GTCbio
Kristen Starkey
626-256-6405
http://www.gtcbio.com
635 W. Foothill Blvd.
Monrovia, CA 91016
fax: 626-466-4433
Kristen Starkey
626-256-6405
http://www.gtcbio.com
635 W. Foothill Blvd.
Monrovia, CA 91016
fax: 626-466-4433
Contact
Categories